10th Sep 2019 7:00 am |
RNS |
University of Sheffield Research Collaboration |
2nd Sep 2019 7:00 am |
RNS |
XF Drug platform data presented at EuroBiofilms |
15th Aug 2019 12:20 pm |
RNS |
Holding(s) in Company |
31st Jul 2019 7:00 am |
RNS |
Presentation at Gordon Research Conference |
19th Jul 2019 3:12 pm |
RNS |
Holding(s) in Company |
4th Jun 2019 2:39 pm |
RNS |
Grant of Options |
4th Jun 2019 12:06 pm |
RNS |
Result of AGM |
9th May 2019 2:06 pm |
RNS |
Appointment of NOMAD and Joint Broker |
29th Apr 2019 2:28 pm |
RNS |
Posting of Annual Report and Notice of AGM |
9th Apr 2019 7:00 am |
RNS |
Final Results |
5th Apr 2019 5:06 pm |
RNS |
Exercise of Options |
1st Apr 2019 3:03 pm |
RNS |
Exercise of Options |
28th Mar 2019 6:13 pm |
RNS |
Exercise of Options |
27th Mar 2019 7:00 am |
RNS |
MedPharm to develop new XF-drug formulations |
22nd Mar 2019 9:47 am |
RNS |
Notice of Results |
6th Mar 2019 6:00 pm |
RNS |
Exercise of Options |
28th Jan 2019 7:00 am |
RNS |
Second positive phase 1 trial data for XF-73 |
25th Jan 2019 7:00 am |
RNS |
New grant awarded under UK-China AMR programme |
24th Jan 2019 11:50 am |
RNS |
Destiny Pharma notes UK 5-year action plan on AMR |
1st Nov 2018 7:00 am |
RNS |
Research collaboration with Southampton University |
25th Oct 2018 4:05 pm |
RNS |
Grant of Options |
25th Oct 2018 7:00 am |
RNS |
Directorate Change |
24th Oct 2018 7:00 am |
RNS |
UK government highlights global threat of AMR |
19th Oct 2018 7:00 am |
RNS |
BIA celebrates UK bioscience innovative |
26th Sep 2018 7:00 am |
RNS |
Dr Jesús González appointed Chief Medical Officer |
26th Sep 2018 7:00 am |
RNS |
Interim results for six months ended 30 June 2018 |
6th Sep 2018 7:00 am |
RNS |
Directorate Change |
26th Jul 2018 7:00 am |
RNS |
Positive Phase 1 skin irritation study with XF-73 |
17th Jul 2018 7:00 am |
RNS |
Research collaboration with Aston University |
11th Jul 2018 7:00 am |
RNS |
Notice of Results |
21st Jun 2018 7:00 am |
RNS |
Directorate Change |
14th Jun 2018 7:00 am |
RNS |
Destiny Pharma notes FDA statement on AMR focus |
5th Jun 2018 12:47 pm |
RNS |
Director/PDMR Shareholding |
31st May 2018 12:30 pm |
RNS |
Result of AGM |
30th May 2018 7:00 am |
RNS |
Destiny Establishes Scientific Advisory Board |
23rd Apr 2018 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
12th Apr 2018 7:00 am |
RNS |
Destiny Pharma announces clinical update on XF-73 |
12th Apr 2018 7:00 am |
RNS |
Final Results |
23rd Mar 2018 7:00 am |
RNS |
Notice of Full Year Results |
22nd Mar 2018 7:00 am |
RNS |
Appointment of Joint Broker |